Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 8, 2020
Primary lateral sclerosis: consensus diagnostic criteria
Martin R Turner, Richard J Barohn, Philippe Corcia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 11, 2021
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis
Bas C Stunnenberg, Esther C Merkus, Joost Raaphorst, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 16, 2023
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure
Anika Varma, Jennifer Weinstein, Jamison Seabury, et al.
Brain : a Journal of Neurology
|
June 18, 2013
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes
Jaya R Trivedi, Brian Bundy, Jeffrey Statland, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
Zachary Macchi, Yunxia Wang, Dan Moore, et al.
Neurology
|
May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar, Lanyu Zhang, Lily Wang, et al.
Journal of Comparative Effectiveness Research
|
August 22, 2025
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial
Dmitry Vlodavets, Shiwen Wu, Anna Kostera-Pruszczyk, et al.
Muscle & Nerve
|
November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis
Salman Bhai, Todd Levine, Dan Moore, et al.
Science Translational Medicine
|
March 25, 2016
Targeting protein homeostasis in sporadic inclusion body myositis
Mhoriam Ahmed, Pedro M Machado, Adrian Miller, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
Stacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 8, 2020
Primary lateral sclerosis: consensus diagnostic criteria
Martin R Turner, Richard J Barohn, Philippe Corcia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 11, 2021
N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis
Bas C Stunnenberg, Esther C Merkus, Joost Raaphorst, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
May 16, 2023
The amyotrophic lateral sclerosis-health index (ALS-HI): development and evaluation of a novel outcome measure
Anika Varma, Jennifer Weinstein, Jamison Seabury, et al.
Brain : a Journal of Neurology
|
June 18, 2013
Non-dystrophic myotonia: prospective study of objective and patient reported outcomes
Jaya R Trivedi, Brian Bundy, Jeffrey Statland, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement
Zachary Macchi, Yunxia Wang, Dan Moore, et al.
Neurology
|
May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar, Lanyu Zhang, Lily Wang, et al.
Journal of Comparative Effectiveness Research
|
August 22, 2025
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial
Dmitry Vlodavets, Shiwen Wu, Anna Kostera-Pruszczyk, et al.
Muscle & Nerve
|
November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis
Salman Bhai, Todd Levine, Dan Moore, et al.
Science Translational Medicine
|
March 25, 2016
Targeting protein homeostasis in sporadic inclusion body myositis
Mhoriam Ahmed, Pedro M Machado, Adrian Miller, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
Stacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Page
of 4